Le développement préclinique et clinique, la production et la commercialisation de produits à visée thérapeutique humaine.
Localisation : Nouzilly (31)
Site web : http://www.igyxos.com/
Localisation : Nouzilly (31)
Site web : http://www.igyxos.com/
Total raised: $8.53M
Investors 2
| Date | Name | Website |
| - | Sofimac In... | sofimac-im... |
| - | GO Capital... | gocapital.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.03.2019 | Series A | $8.53M | - |
Mentions in press and media 6
| Date | Title | Description |
| 04.06.2024 | Studies Suggest Sperm Counts Have Declined 50% in the Last 50 Years; New Innovation May Help Address Male Infertility | Because IGX12 could potentially be used to treat both male and female infertility, a couple could be treated simultaneously to increase chances of success” — Marie-Christine Maurel, Ph.D., Chief Science Officer & Founder at IgyxosNOUZIL... |
| 29.05.2024 | Igyxos Biotherapeutics to Attend BIO International Convention 2024 | NOUZILLY, FRANCE, May 29, 2024 /EINPresswire.com/ -- Igyxos Biotherapeutics (“Igyxos” or “the Company”), an emerging biopharmaceutical company specializing in infertility solutions, is pleased to announce its participation in the upcoming 2... |
| 14.11.2023 | Igyxos Announces Successful Closure of Second Largest Investment Round in its History, Marking a Milestone in its Growth | Financial proceeds will be used to advance Igyxos infertility breakthrough treatment towards its goal to transform lives of many facing fertility problems I have worked with thousands of families facing this devastating problem and have con... |
| 23.03.2019 | Igyxos raises €7.5M in Series A Funding | Igyxos, a Nouzilly, France-based biotechnology company specializing in the development of a new treatment for female and male infertility, raised €7.5m in Series A funding. Backers included: – Bpifrance, via the Accelerate Biotechnologies S... |
| 21.03.2019 | French biotech startup Igyxos raises €7.5 million Series A to develop a new treatment for infertility | Infertility affects about 70 million women and 30 million men worldwide, which is in many cases linked to hormonal imbalances. Current infertility treatments are largely unsuccessful; on average, only 50% of couples treated have a child aft... |
| - | Igyxos lève 7,5M€ | (21/03/19) Igyxos lève 7,5M€ pour financer le développement préclinique et clinique de son candidat médicament First-In-Class dans le traitement de l’infertilité humaine Nouzilly, le 21 Mars 2019 – Igyxos, société de biotechnologie spéci... |